Actinogen Medical Investor Relations Material

Actinogen Medical Limited is a biotechnology company focused on the development of treatments for cognitive impairment and neurodegenerative diseases. The company’s primary research centers on therapies that target neurological pathways involved in conditions such as Alzheimer's disease and other forms of cognitive decline. Actinogen Medical leverages its proprietary drug development platform to create innovative solutions aimed at improving brain health and cognitive function. Actinogen Medical Limited is headquartered in Sydney, Australia, and its shares are listed on the ASX.